ARMOSTEOS, created in 2005 (United States), from 142 sister brands and 17477 competing brands. The ARMOSTEOS brand is owned by Amgen, a company listed in New York. The sector of ARMOSTEOS is Drug Manufacturers.
Investment simulator :
Portfolio valuation
Amgen
(ARMOSTEOS)
over 5 years*
USD 412.68